MSD said the Dundalk deal further diversified the group’s network in Ireland, where each of its eight sites, including its five manufacturing facilities, operate in different segments of its ...

"Our partnership with MSD Ireland spans nearly 50 years, and it’s exciting to see the company continue to both deepen and broaden its roots all across the country, expanding to its new location ...

WuXi Biologics subsidiary WuXi Vaccines has agreed to sell its vaccine manufacturing facility in Dundalk, Ireland, to MSD for approximately $500m. Expected to close in the first half of 2025 ...